Background: The 2019 novel corona virus disease (COVID-19) pandemic broke out in Wuhan, Hubei province in China in December 2019. Available research so far showed that Otolaryngologists had an elevated risk of exposure to SARS-CoV-2 due to the high viral load in the respiratory tract, which is the primary area of examination and instrumentation. We aimed to present our findings on the impact of this pandemic on Otolaryngology practice in Nigeria. Materials and Methods: This study was conducted online in September, 2020 amongst otolaryngologists in secondary and tertiary health centers across Nigeria using the survey monkey. Analysis was done using SPSS version 20. Results: A total of 102 ORL practitioners in Nigeria were assessed in this study. The mean age of the respondents was 42.4 ± 7.9 years; majority (54.9%) were Consultants and their duration of ORL practice ranged between 1 - 37 years. All the respondents felt being an ENT Surgeon exposes them to higher risk of contracting COVID-19 in their practice while 93% of them felt unsafe to perform throat examination during COVID-19 pandemic. Similarly, 74.5% feel unsafe to perform rhinoscopy while 67.7% of the respondents feel unsafe to do anterior rhinoscopy, posterior rhinoscopy and rigid nasal endoscopy. Conclusion: Otolaryngologist is at high risk of being infected with SARS COV-2 as they cope with upper respiratory tract during diagnosis, clinical review, sampling and surgery. The pandemic has affected almost all aspects of Otolaryngologic practice in Nigeria.
References
[1]
Zhou, P., Yang, X.L., Wang, X.G., et al. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
[2]
Coronavirus Resource Center (2020) Johns Hopkins University & Medicine. https://coronavirus.jhu.edu
[3]
Gorbalenya, A.E., Baker, S.C., Baric, R.S., et al. (2020) Severe Acute Respiratory Syndrome-Related Coronavirus: The Species and Its Viruses—A Statement of the Coronavirus Study Group. https://doi.org/10.1101/2020.02.07.937862
[4]
Chan, Y., Wong, W. and Lam, W. (2020) Practical Aspects of Otolaryngologic Clinical Services during the 2019 Novel Coronavirus Epidemic. An Experience in Hong Kong. JAMA Otolaryngology—Head & Neck Surgery, 146, 519-520. https://doi.org/10.1001/jamaoto.2020.0488
[5]
European Rhinologic Society (2020). https://www.europeanrhinologicsociety.org
[6]
GOV.UK (2020) COVID-19: Infection Prevention and Control. https://www.gov.uk/government/publications/wuhannovel-coronavirusinfectionpreventionandcontrol
[7]
Han, D.-H., Willeke, K. and Colton, C.E. (1997) Quantitative Fit Testing Techniques and Regulations for Tight-Fitting Respirators: Current Methods Measuring Aerosol or Air Leakage, and New Developments. American Industrial Hygiene Association Journal, 58, 219-228. https://doi.org/10.1080/15428119791012874
[8]
National Institute for Occupational Safety and Hygiene (NIOSH) (1996) NIOSH Guide to the Selection and Use of Particulate Respirators Certified under 42 CFR 84. National Institute for Occupational Safety and Hygiene (NIOSH), Cincinnati, DHHS (NIOSH) Publication No. 96-101.
[9]
Centers for Disease Control and Prevention (CDC) (2015) Guidance on Personal Protective Equipment (PPE) to Be Used by Healthcare Workers during Management of Patients with Confirmed Ebola or Persons under Investigation (PUIs) for Ebola Who Are Clinically Unstable or Have Bleeding, Vomiting, or Diarrhea in U.S. Hospitals, Including Procedures for Donning and Doffing PPE. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta. http://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html
[10]
Lee, S.-A., Grinshpun, S.A. and Reponen, T. (2008) Respiratory Performance Offered by N95 Respirators and Surgical Masks: Human Subject Evaluation with NaCl Aerosol Representing Bacterial and Viral Particle Size Range. Annals of Occupational Hygiene, 52, 177-185. https://doi.org/10.1093/annhyg/men005
[11]
Loeb, M., Dafoe, N., Mahony, J., et al. (2009) Surgical Mask vs N95 Respirator for Preventing Influenza among Health Care Workers: A Randomized Trial. The Journal of the American Medical Association, 302, 1865-1871. https://doi.org/10.1001/jama.2009.1466
[12]
Medicines and Healthcare Products Regulatory Agency (2010) Medical Devices Directive. Medicines and Healthcare Products Regulatory Agency, London.
[13]
UK Government (2002) Statutory Instrument. Personal Protective Equipment Regulations. HMSO, London, 1144.
[14]
Kampf, G. and Kramer, A. (2004) Epidemiologic Background of Hand Hygiene and Evaluation of the Most Important Agents for Scrubs and Rubs. Clinical Microbiology Reviews, 17, 863-893. https://doi.org/10.1128/CMR.17.4.863-893.2004
[15]
CDC (2019) Show Me the Science—When & How to Use Hand Sanitizer in Community Settings [WWW Document]. https://www.cdc.gov/handwashing/show-me-the-science-hand-sanitizer.html
[16]
Ministério da Saúde (2013) RESOLUC¸ÃO-RDC N◦6, DE10-DE MARC¸O DE [Internet]. http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2013/rdc000610032013.html
[17]
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., et al. (2020) SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. The New England Journal of Medicine, 382, 1177-1179. https://doi.org/10.1056/NEJMc2001737
[18]
Chang, D., Xu, H., Rebaza, A., Sharma, L. and Dela Cruz, C.S. (2020) Protecting Health-Care Workers from Subclinical Coronavirus Infection. The Lancet Respiratory Medicine, 8, e13. https://doi.org/10.1016/S2213-2600(20)30066-7
[19]
Megan, L.R., Valerie, G. and Ashish, K.J. (2020) Critical Supply Shortages—The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. The New England Journal of Medicine, 382, e41.
[20]
World Health Organization (2020) Infection Prevention and Control of Epidemic- and Pandemic-Prone Acute Respiratory Infections in Health Care: WHO Guidelines. http://apps.who.int/iris/10665/112656
[21]
Centers for Disease Control and Prevention (2020) Interim Infection Prevention and Control Recommendations for Patients with Known or Patients under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html
